Dataset: Fate determination of adult human glial progenitor cells
Glial progenitor cells comprise the most abundant population of progenitor cells in the adult human brain. They are responsible for CNS...
Glial progenitor cells comprise the most abundant population of progenitor cells in the adult human brain. They are responsible for CNS remyelination, and likely contribute to the astrogliotic response to brain injury and degeneration as well. Adult human GPCs are biased to differentiate as oligodendrocytes and elaborate new myelin, and yet they retain multilineage plasticity, and can give rise to neurons as well as astrocytes and oligodendrocytes once removed from the adult parenchymal environment. GPCs retain strong mechanisms for cell-autonomous self-renewal, and yet both their phenotype and fate may be dictated by their microenvironment. Using the transcriptional profiles of acutely isolated GPCs, we have begun to understand the operative ligand-receptor interactions involved in these processes, and have identified several key signaling pathways by which adult human GPCs may be reliably instructed to either oligodendrocytic or astrocytic fate. In addition, we have noted significant differences between the expressed genes and dominant signaling pathways of fetal and adult human GPCs, as well as between rodent and human GPCs. The latter data in particular call into question therapeutic strategies predicated solely upon data obtained using rodents, while perhaps highlighting the extent to which evolution has been attended by the phylogenetic modification of glial phenotype and function. Human adult brain dissociates were sorted for one of three markers, either GLT1 (astrocyte, n =3), CD11b (microglia, n=4) or A2B5 (glial progenitor cell, n=7). In addition to positively selected, the negative fraction and unsorted dissociates were collected as matched controls for each sort.
- Species:
- human
- Samples:
- 24
- Source:
- E-GEOD-36634
- Updated:
- Dec.12, 2014
- Registered:
- Jul.12, 2014
Sample | PATHOLOGY | BRAIN REGION | PATIENTID | SORTFRACTION |
---|---|---|---|---|
GSM897785 | epilepsy | WM | 4 | pos |
GSM897784 | epilepsy | WM | 3 | pos |
GSM897783 | epilepsy | CTX | 129 | pos |
GSM897782 | epilepsy | CTX | 129 | NA |
GSM89778 | epilepsy | WM | 129 | pos |
GSM897780 | epilepsy | WM | 129 | NA |
GSM897779 | epilepsy | WM | 139 | pos |
GSM897778 | epilepsy | WM | 139 | NA |
GSM897777 | epilepsy | CTX | 92 | NA |
GSM897776 | epilepsy | CTX | 92 | pos |
GSM897775 | epilepsy | WM | 92 | NA |
GSM897774 | epilepsy | WM | 92 | pos |
GSM897773 | epilepsy | CTX | 110 | NA |
GSM897772 | epilepsy | CTX | 110 | pos |
GSM89777 | epilepsy | WM | 110 | NA |
GSM897770 | epilepsy | WM | 110 | pos |
GSM897769 | epilepsy | WM | 2 | pos |
GSM897768 | Diffuse astrocytoma | CTX | 206 | neg |
GSM897767 | Diffuse astrocytoma | CTX | 206 | pos |
GSM897766 | epilepsy | CTX | 197 | neg |
GSM897765 | epilepsy | CTX | 197 | pos |
GSM897764 | epilepsy | CTX | 182 | neg |
GSM897763 | epilepsy | CTX | 182 | pos |
GSM897762 | epilepsy | WM | 1 | pos |